FDA clears bioMerieux's MRSA test

05/25/2011 | MedCityNews.com

The FDA has granted bioMerieux 510(k) clearance to market NucliSENS EasyQ MRSA, a molecular test that can spot seven types of methicillin-resistant Staphylococcus aureus. The test can process up to 46 samples and generate results in three hours.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR